Genesis

Approach

Genesis chose Thermal to develop and execute a communications strategy that would amplify its momentum and position the company as a leader in AI-driven drug discovery. Together, we:

• • Refined Genesis’ positioning to highlight its pioneering AI technology and real-world impact in accelerating drug development.
  • Amplified key milestones including its strategic collaboration with NVIDIA and leadership appointments, ensuring these announcements resonated with investors, partners, and the broader biotech and AI communities.
  • Enhanced executive thought leadership by developing narratives that showcased Genesis’ unique approach and securing high-impact media opportunities.
  • Built lasting media relationships with top-tier journalists covering AI, biotech, and drug discovery, ensuring continued visibility for Genesis’ breakthroughs.

Impact

Through our ongoing collaboration, Genesis Therapeutics has:

• • Strengthened its industry leadership by showcasing the transformative potential of its AI-driven drug discovery platform.
  • Expanded its visibility through media coverage of its NVIDIA partnership, leadership expansion, and broader company vision.
  • Reinforced its position as a top innovator at the intersection of AI and biotech, attracting interest from investors, partners, and the scientific community.

Thermal continues to work with Genesis to shape its narrative, support strategic announcements, and ensure the company’s breakthroughs are recognized at the highest levels of biotech and AI.